Skip to main content

Overview


Dr. Liangbo (Linus) Shen is a vitreoretinal surgery fellow at Duke University School of Medicine. He graduated summa cum laude in Biomedical Engineering from Duke, where he co-invented a patented stereoscopic heads-up display system for ophthalmic surgery and advanced intraoperative optical coherence tomography. He went on to earn his medical degree cum laude from Yale School of Medicine, where he co-developed the “entry time realignment” statistical method that enabled long-term natural history studies of geographic atrophy, choroideremia, Stargardt disease, Huntington’s disease, and USH2A-retinopathy. He also identified novel imaging biomarkers and developed a pixel-based analysis method that can reduce clinical trial sample sizes for geographic atrophy by more than tenfold compared with conventional methods.

Dr. Shen completed rigorous clinical and surgical training during his ophthalmology residency at the University of California, San Francisco. At UCSF, he also pursued research in imaging biomarkers of age-related macular degeneration and inherited retinal degenerations. His work included leading analyses for the METforMIN randomized trial on metformin and geographic atrophy progression, investigating cone structure changes in choroideremia, and inventing a syringe attachment for one-handed anterior chamber paracentesis.

Now at Duke, Dr. Shen continues to refine pixel-based imaging analysis to improve trial efficiency and to evaluate treatment response in geographic atrophy and inherited retinal degenerations. He has authored or co-authored more than 50 peer-reviewed publications in high-impact journals including Ophthalmology, JAMA Ophthalmology, and the American Journal of Ophthalmology.

Dr. Shen has been recognized with numerous national awards, including the Heed Fellowship, AUPO/RPB Resident and Fellow Research Forum Award, and best research awards at conferences. He has delivered talks on his research at major national and international conferences, including ARVO, AAO, ASRS, and AUPO.

Deeply committed to advancing the understanding of retinal diseases, Dr. Shen integrates engineering, imaging, and clinical research to develop diagnostics and treatments that improve patient care.

Current Duke Appointments & Affiliations


Provisional Faculty in the Department of Ophthalmology · 2025 - Present Ophthalmology, Vitreoretinal Diseases & Surgery, Ophthalmology

Recent Scholarly Works


Intereye Correlation in Bilateral Geographic Atrophy: Morphology and Growth Rates in the Age-Related Eye Disease Study.

Journal article Ophthalmol Sci · October 2026 PURPOSE: To evaluate intereye correlation in geographic atrophy (GA) lesion morphology, topography, and growth rates, and whether fellow eyes could improve trial efficiency as internal controls. DESIGN: Secondary analysis of a multicenter, prospective, ran ... Full text Link to item Cite

Real-World Geographic Atrophy Growth Before and After Intravitreal Avacincaptad Pegol Treatment: A Retrospective Cohort Study

Preprint · September 29, 2026 AbstractBackground/Objectives: To evaluate whether intravitreal avacincaptad pegol (ACP) slows geographic atrophy (GA) progression in routine clinical practice. Subjects/Methods: This single-centre retrospective cohort ... Full text Cite

A Novel Pixel-Based Spatial Modeling Framework for Mapping At-Risk Retina in Geographic Atrophy Progression.

Journal article Ophthalmol Sci · September 2026 PURPOSE: To develop a Pixel-based At-risk Retina Mapping (PARM) framework quantifying local geographic atrophy (GA) progression in nonexudative age-related macular degeneration and evaluate its predictive performance and statistical efficiency relative to ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Novel Pixel Based Analysis to Improve Clinical Trial Efficiency in Stargardt Disease

ResearchPI-Fellow · Awarded by Foundation Fighting Blindness, Inc · 2026 - 2027

View All Grants

Education


Yale University, School of Medicine · 2021 M.D.